4th International Symposium on Inherited Diseases of the Pancreas: November 7-9, 2003, Chicago, Ill., USA

Pancreatology

Volumn 3, Issue 6, 2003, Pages 520-532

  Andren Sandberg A ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; TRYPSIN;

ACINAR CELL; CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; MEDICAL LITERATURE; MEMBRANE POTENTIAL; PANCREATITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

EID: 1342269783     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000076367     Document Type: Conference Paper

References (26)

1. Szmola R, Kukor Z, Sahin-Toth M: The evolutionary G198R mutations is responsible for the inhibitor resistance and substrate restriction of human mesotrypsin (abstract). Pancreatology 2003;3:433.
2. Kukor Z, Szmola R, Sahin-Toth M: Human mesotrypsin rapidly degrades trypsin inhibitors (abstract). Pancreatology 2003;3:434.
3. Szmola R, Kukor Z, Sahin-Toth M: Cathepsin B preferentially activates mesotrypsinogen of the three human trypsinogen isoforms (abstract). Pancreatology 2003;3:434.
4. Wilschanski M, Yahav J, Blau H, Bentur L, Rivlin J, Aviram M, Yaakov Y, Bebok S, Shushan L, Kerem B, Kerem E: Restoration of CFTR function by gentamicin in cystic fibrosis patients carrying stop mutations: A double-blind placebo-controlled trial (abstract). Pancreatology 2003;3:430.
5. Férec C, Chen JM, Raguénès O, Audrézet MP: Rapid detection of genomic rearrangements in the cystic fibrosis transmembrane conductance regulator (CFTR) gene by quantitative multiplex PCR amplification of short fluorescent fragments: Extensive allelic heterogeneity and diverse mutational mechanisms (abstract). Pancreatology 2003;3:439.
6. Simon P, Weiss FU, Bogdanova N, Lerch MM: Prevalence of CFTR gene mutations in patients with idiopathic chronic pancreatitis (abstract). Pancreatology 2003;3:433.
7. Korczowski B, Mountford R, Neoptolemos JP, Ellis IH: The R122H cationic trypsinogen gene mutation in two Polish families with hereditary pancreatitis (abstract). Pancreatology 2003;3:430-431.
8. Chen JM, Le Maréchal C, Raguénes O, Férec C: Two nowel severe mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) cause familial or/and hereditary pancreatitis (abstract). Pancreatology 2003;3:438.
9. Weiss FU, Simon P, Hohoff C, Brinkmann B, Lerch MM: The incidence of heriditary pancreatitis in Westphalia is not related to a founder effect (abstract). Pancreatology 2003;3:433.
10. Oruc N, Kutlu OC, Barmada MM, Whitcomb DC: Angiotensin-converting enzyme polymorphism is not associated with chronic pancreatitis (abstract). Pancreatology 2003;3:435.
11. Fesinmeyer MD, Austin MA, Bowen DJ, Malone KE, Potter JD: Familial aggregation of pancreatic cancer in the Northwest Cancer Genetics Network (abstract). Pancreatology 2003;3:431.
12. Fernandez-Zapico ME, Molina JR, Ahlquist DA, Urrutia R: Functional characterization of KFL11, a novel TGF-β-regulated tumor suppressor for pancreatic cancer (abstract). Pancreatology 2003;3:436.
13. 11]SP: A novel potent inhibitor of mitogenic signaling and growth in vitro and in vivo in human pancreatic cancer (abstract). Pancreatology 2003;3:431.
14. Austin MA, Bowen DJ, Burke W, Fishbach A, Fesinmeyer MD, Potter JD: Pilot study BRCA2 and CDKN2A mutations among pancreatic cancer cases in the Northwest Cancer Genetics Network (abstract). Pancreatology 2003;3:432.
15. Schnekenburger J, Bredebusch I, Lerch MM, Domschke W: Different function of E-cadherin in the metastasis of pancreatic tumor cells (abstract). Pancreatology 2003;3:435.
16. Callahan G, Delgado S, Bensi D, Huggins L, Urrutia R: The interaction of a chromosomal form of HP1 gamma with Ku70 in pancreatic cancer cells suggests a role for this protein complex in the maintenance of chromosomal instability (abstract). Pancreatology 2003;3:436.
17. Earl J, Yan L, McFaul CD, Ellis IH, Leslie J, Rieder H, Sina-Frey M, Hahn SA, Bartsch DK, Kress R, Greenhalf WG, Neoptolemos JP: Evidence for the association of the 4q32-34 locus and pancreatic cancer in European FPC families (abstract). Pancreatology 2003;3:437.
18. Park YM, George RD, Mackey JA, Pouge-Geile KL: Functional isolation of pancreatic tumor suppressor genes (abstract). Pancreatology 2003;3:439.
19. Pouge-Geile KL, Mackey JA, George RD, Crispin D, Lee KK, Moser AJ, Wood PG, Brentnall T, Whitcomb DC: Identification of markers for the early detection of pancreatic cancer (abstract). Pancreatology 2003;3:439-440.
20. Sherman S, Brand R, Ketcham M, Shats O, Mashinson Y, Shats D: Pancreatic Cancer Colloborative Registry (abstract). Pancreatology 2003;3:436.
21. McFaul CD, Yan L, Howes N, Wong T, Leslie J, Threadgold J, Lombard M, Smart H, Gilmore I, Evans J, Sutton R, Ellis IH, Greenhalf WG, Neoptolemos JP: Analysis of p53 status in pancreatic juice by yeast functional assay as a potential screening test for inherited pancreatic cancer (abstract). Pancreatology 2003;3:434.
22. Costa J, Taraffa G, Ladner D, Brand R, Topazin M, Lizardi P, Capella G, Lynch H: Measurement of pancreatic cancer risk by mutational load distribution analysis in pancreatic cancer-prone families (abstract). Pancreatology 2003;3:438.
23. Ellis IH, McFaul CD, Lerch MM, Neoptolemos JP: Potential interest in developing pre-implantation genetic diagnosis (PGD) for hereditary pancreatitis (abstract). Pancreatology 2003;3:440.
24. Brand R, Maisonneuve P, Lowenfels A, Deters C, Lynch H: Effect of smoking on the risk for developing pancreatic cancer in pancreatic cancer prone kindreds (abstract). Pancreatology 2003;3:437.
25. Hlouschek V, Mooren F, Turi S, Schnekenburger J, Domschke W, Lerch MM: Prophylactic magnesium treatment attenuates the onset and course of acute pancreatitis (abstract). Pancreatology 2003;3:432.
26. Ellis IH, McRonald F, Neoptolemos JP, Kerzin-Storrar L: Psychosocial impact of hereditary pancreatitis, and of participation in the EUROPAC research register (abstract). Pancreatology 2003;2:430.